Legal and Regulatory Aspects of Medical Cannabis in the United States

Author:

Hong Genewoo12,Sideris Alexandra1,Waldman Seth12,Stauffer Joe34,Wu Christopher L.12

Affiliation:

1. Department of Anesthesiology, Hospital for Special Surgery, New York, New York

2. Department of Anesthesiology, Weill Cornell Medicine, New York, New York

3. Alta Life Sciences, LLC, Sarasota, Florida

4. Antibe Therapeutics, Toronto, Ontario, Canada.

Abstract

Federal and state laws in the United States governing the use of cannabis are rapidly evolving. Under federal law, marijuana and its derivatives remain schedule I, defined as substances having no currently accepted medical use and a high potential for abuse. Hemp and its derivatives, in contrast, have been removed from schedule I. At the state level, a majority of states have passed laws legalizing cannabis in some form, although these laws vary from state to state in terms of the extent to which use is permitted, approved medical uses, and the types of regulation placed on commercial activity and quality control. This inconsistency has contributed to uncertainty among medical providers and their patients. In this review, we provide a brief account of the evolution and current state of federal and state laws and regulatory agencies involved in overseeing medical cannabis use in the United States.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Anesthesiology and Pain Medicine

Reference30 articles.

1. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.;Pertwee;Br J Pharmacol,2008

2. Isolation, structure and partial synthesis of an active constituent of hashish.;Gaoni;J Am Chem Soc,1964

3. The structure of cannabidiol.;Mechoulam;Tetrahedron,1963

4. Diversity of molecular targets and signaling pathways for CBD.;de Almeida;Pharmacol Res Perspect,2020

5. On the preparations of the Indian Hemp, or Gunjah: cannabis indica their effects on the animal system in health, and their utility in the treatment of tetanus and other convulsive diseases.;O’Shaughnessy;Prov Med J Retrosp Med Sci,1839

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3